Protocol summary

Summary
Objectives: Efficacy of oral diazepam in Frequency, severity and duration reduction due to bruxism in children, Isfahan, 2014/2015. Design: Bruxism is a common childhood problem woreldwide. There is no effective therapy of the disorder in the literature. So we decide to evaluate the efficacy of the drug in 90 otherwise healthy children in age of 2-15 years in a triple blind clinical trial. Setting and conduct: Enrolled children are divided to three groups as low dose diazepam, high dose diazepam and placebo. The drugs are blindly packed in different colors for age groups of 2-8 and 8-15 year. For age group of 2-8 years 2.5 mg Diazepam(code A- half a 5 mg pill) is considered as low dose, 5 mg Diazepam( code B- half a 10 mg pill) as high dose, and half an identical placebo pill( code c-) as a placebo drug. For age group of 8-15 years 5 mg Diazepam(code A- 5 mg pill) is considered as low dose, 10 mg Diazepam( code B- 10 mg pill) as high dose, and an identical placebo pill ( code C-) as a placebo drug. The researcher will assess inclusion criteria and include the children in the study. Each participant will receive 10 drug and advise to consume before bed for 5 nights and then as alternate night for 10 days. After that, we will follow up patients during 2 weeks, 1months and 3months in order to check symptoms severity, possible adverse effects and consumption/avoiding the consumption of the drug. Data will be analyzed by SPSS Inclusion criteria including: Bruxism reported by parents; No previous seizure disorder or abnormal movement during sleep; Age 2-15 years; Not taking any medications that affects the neuromuscular system, such as anticonvulsants, benzodiazepines, muscle relaxant and antidepressants; Visual Analogue Score (VAS) will be calculated for included patients by the score of duration, intensity and frequency of bruxism episodes. Exclusion criteria including: Inability to take a pill; Drug hypersensivity. Interventions: For age group of 2-8 years 2.5 mg Diazepam(code A- half a 5 mg pill) is considered as low dose, 5 mg Diazepam( code B- half a 10 mg pill) as high dose, and half an identical placebo pill( code c-) as a placebo drug. For age group of 8-15 years 5 mg Diazepam(code A- 5 mg pill) is considered as low dose, 10 mg Diazepam( code B- 10 mg pill) as high dose, and an identical placebo pill ( code C-) as a placebo drug. Each participant will receive 10 drug and advise to consume before bed for 5 nights and then as alternate night for 10 days. Main outcome measures: Intensity, Frequency.

General information

Acronym
Efficacy of diazepam in childhood bruxism
IRCT registration information
IRCT registration number: IRCT2016031225780N2
Registration date: 2016-08-21, 1395/05/31
Registration timing: retrospective

Last update:
Update count: 0
Registration date
2016-08-21, 1395/05/31
Registrant information
Name
Naser Mostafavy
Name of organization / entity
Department of Pediatrics , School of Medical , Isfahan University of Medical Sciences, Hezar Jerib
Country
Iran (Islamic Republic of)
Phone
none
Email address
n_mostafavy@med.mui.ac.ir
Recruitment status
Recruitment complete
Funding source
Vice Chancellor for Research, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, I.R.Iran
Expected recruitment start date
2015-06-22, 1394/04/01
Expected recruitment end date
2016-03-17, 1394/12/27
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Efficacy of Oral Diazepam in Decrease Frequency,Severity and Duration of Bruxism in Children With Bruxism in Isfahan in 2014/2015
Public title
Efficacy of Oral Diazepam in Decrease Frequency,Severity and Duration of Bruxism in Children With Bruxism in Isfahan in 2014/2015
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion criteria including: Bruxism reported by parents; No previous seizure disorder or abnormal movement during sleep; Age 2-15 years; Not taking any medications that affects the neuromuscular system, such as anticonvulsants, benzodiazepines, muscle relaxant and antidepressants; Visual Analogue Score (VAS) will be calculated for included patients by the score of duration, intensity and frequency of bruxism episodes. Exclusion criteria including: Inability to take a pill; Drug hypersensivity.
Age
From 2 years old to 15 years old
Gender
Both
Phase
2-3
Groups that have been masked
No information
Sample size
Target sample size:
Randomization (investigator's opinion)
Randomized
Randomization description
Blinding (investigator's opinion)
Triple blinded
Blinding description
Placebo
Used
Assignment
Parallel
Other design features

Secondary Ids

empty

Ethics committees

1

Ethics committee
Name of ethics committee
Ethics Committee, Isfahan University of Medical Sciences
Street address
Ethics Committee, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, I.R.Iran
City
Isfahan
Postal code
8174673461
Approval date
2015-05-27, 1394/03/06
Ethics committee reference number
ir.mui.rec.1394.3.307

Health conditions studied

1

Description of health condition studied
Bruxism
ICD-10 code
F45.8
ICD-10 code description
other somatoform disorders

Primary outcomes

1

Description
Bruxism
Timepoint
2 Weeks, 1 Month , 3 Month after adminstration
Method of measurement
Questionnaire

Secondary outcomes

1

Description
Intensity, Frequency
Timepoint
2 Week, 2 Month, 6 Month
Method of measurement
Questionnaire

Intervention groups

1

Description
To subgroups 3 from both age group, placebo was gave as followa; 2-8-year-old: half a placebo tablet 8-12-year-old: a placebo tablet Other study process is similar for placebo and diazepam.
Category
Treatment - Drugs

2

Description
For age group of 2-8 years 2.5 mg Diazepam(code A- half a 5 mg pill) is considered as low dose and 5 mg Diazepam( code B- half a 10 mg pill) as high dose. For age group of 8-15 years 5 mg Diazepam(code A- 5 mg pill) is considered as low dose and 10 mg Diazepam( code B- 10 mg pill) as high dose.Each participant will receive 10 drug and advise to consume before bed for 5 nights and then as alternate night for 10 days.
Category
Treatment - Drugs

Recruitment centers

1

Recruitment center
Name of recruitment center
EmamHossein Hospital, Emamkhomeini street, Isfahan, Iran
Full name of responsible person
Dr Sayed Nasser – Mostafavy, Dr Majid Khademian
Street address
EmamHossein Hospital, Emamkhomeini street, Isfahan, Iran
City
Isfahan

Sponsors / Funding sources

1

Sponsor
Name of organization / entity
Vice Chancellor for Research, Isfahan University of Medical Sciences
Full name of responsible person
ice Chancellor for Research, Isfahan University of Medical Sciences, Maryam V akili
Street address
Vice Chancellor for Research, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, I.R.Iran
City
Isfahan
Grant name
394
Grant code / Reference number
307
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Vice Chancellor for Research, Isfahan University of Medical Sciences
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty

Person responsible for general inquiries

Contact
Name of organization / entity
Vice Chancellor for Research, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan,
Full name of responsible person
Dr Sayed Nasser – Mostafavy, Dr Majid Khademian
Position
Assistance Professor in Pediatrics Department
Other areas of specialty/work
Street address
Vice Chancellor for Research, Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, I.R.Iran
City
Isfahan
Postal code
8174673461
Phone
+98 31 3386 8247
Fax
Email
m.khademian@med.mui.ac.ir; n_mostafavy@med.mui.ac.ir
Web page address

Person responsible for scientific inquiries

Contact
Name of organization / entity
Isfahan University of Medical Sciences
Full name of responsible person
Dr Sayed Nasser – Mostafavy, Dr Majid Khademian
Position
Assistance Professor in Pediatrics Department
Other areas of specialty/work
Street address
Department of Pediatrics , School of Medical , Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, I.R.Iran
City
Isfahan
Postal code
Phone
+98 31 3386 8247
Fax
Email
m.khademian@med.mui.ac.ir; n_mostafavy@med.mui.ac.ir
Web page address

Person responsible for updating data

Contact
Name of organization / entity
Isfahan University of Medical Sciences
Full name of responsible person
Dr Sayed Nasser – Mostafavy, Dr Majid Khademian
Position
Assistance Professor in Pediatrics Department
Other areas of specialty/work
Street address
Department of Pediatrics , School of Medical , Isfahan University of Medical Sciences, Hezar Jerib Street, Isfahan, I.R.Iran
City
Isfahan
Postal code
8174673461
Phone
+98 31 3386 8247
Fax
Email
m.khademian@med.mui.ac.ir; n_mostafavy@med.mui.ac.ir
Web page address

Sharing plan

Deidentified Individual Participant Data Set (IPD)
empty
Study Protocol
empty
Statistical Analysis Plan
empty
Informed Consent Form
empty
Clinical Study Report
empty
Analytic Code
empty
Data Dictionary
empty
Loading...